Our first news is that we’ve found some terrific services that we believe will help immensely if you are trading CRISPR Therapeutics AG – take a quick look through the following:
Beat The Market Analyzer: https://logistics-business-review.com/recommended-tool-for-CRSP-investors (this is a fantastic tool – use this to analyze CRISPR Therapeutics AG in much more depth)
MM Publishing: https://logistics-business-review.com/mmpublishing-for-CRSP-investors
Trading Code: https://logistics-business-review.com/tradingcode-for-CRSP-investors
Trader HR: https://logistics-business-review.com/traderHR-for-CRSP-investors
REPORTING FOR 2019-07-15 | LOGISTICS-BUSINESS-REVIEW.COM: We have conducted a deep analysis of how CRISPR Therapeutics AG ($CRSP) has been trading over the last 2 weeks and the past day especially. On its latest session, CRISPR Therapeutics AG ($CRSP) opened at 49.0, reaching a high of 49.555 and a low of 48.42 before closing at a price of 49.11. There was a total volume of 287455.
VOLUME INDICATORS: We saw an accumulation-distribution index of 658.01903, an on-balance volume of -49.18, chaikin money flow of 3.09009 and a force index of -0.1512. There was an ease of movement rating of -0.00555, a volume-price trend of 12.21577 and a negative volume index of 1000.0.
VOLATILITY: We noted an average true range of 1.24108, bolinger bands of 48.50228, an upper bollinger band of 48.24772, lower bollinger band of 48.42, a bollinger high band indicator of nan, bollinger low band indicator of 1.0, a central keltner channel of 48.99167, high band keltner channel of 48.43667, low band keltner channel of 49.54667, a high band keltner channel indicator of 1.0 and a low band keltner channel indicator of 1.0. There was a donchian channel high band of 48.42, a donchian channel low band of 48.42, a donchian channel high band indicator of 1.0, and a donchian channel low band indicator of 1.0.
TREND: We calculated a Moving Average Convergence Divergence (MACD) of -0.00202, a MACD signal of -0.00112, a MACD difference of -0.0009, a fast Exponential Moving Average (EMA) indicator of 48.42, a slow Exponential Moving Average (EMA) indicator of 48.42, an Average Directional Movement Index (ADX) of unknown, an ADX positive of 20.0, an ADX negative of 20.0, a positive Vortex Indicator (VI) of 1.0, a negative VI of 1.0, a trend vortex difference of 0.32406, a trix of 17.57249, a Mass Index (MI) of 1.0, a Commodity Channel Index (CCI) of 66.66667, a Detrended Price Oscillator (DPO) of -9.66201, a KST Oscillator (KST) of 249.29063 and a KST Oscillator (KST Signal) of 249.29063 (leaving a KST difference of -0.58053). We also found an Ichimoku rating of 49.2775, an Ichimoku B rating of 49.2775, a Ichimoku visual trend A of 41.40106, an Ichimoku visual trend B of 42.96979, an Aroon Indicator (AI) up of 4.0 and an AI indicator down of 4.0. That left a difference of -4.0.
MOMENTUM: We found a Relative Strength Index (RSI) of 50.0, a Money Flow Index (MFI) of 100.0, a True Strength Index (TSI) of 100.0, an ultimate oscillator of 94.33705, a stochastic oscillator of 204.5045, a stochastic oscillator signal of 204.5045, a Williams %R rating of 104.5045 and an awesome oscillator of -0.11802.
RETURNS: There was a daily return of 24.92906, a daily log return of -0.18605 and a cumulative return of -0.18587.
What the heck does all of this mean? If you are new to technical analysis, the above may be gibberish to you, and that’s OK (though we do advise learning these things). The bottom line is that AS OF 2019-07-15 (if you are reading this later, the analysis will be out of date), here is what our deep analysis of technical indicators are telling us for CRISPR Therapeutics AG ($CRSP)…
For a more complete analysis, run all of this through the BTMA software. Also, to stay up to date with what is happening on CRISPR Therapeutics AG, we strongly advise CRISPR Therapeutics AG investors to subscribe to MarketBeat.com’s daily email newsletter for updates, news and analyst ratings on stocks like CRISPR Therapeutics AG – without this you are trading blind:
We will of course continue to cover the news and price action of CRISPR Therapeutics AG, but it’s easiest for you to just subscribe to MarketBeat’s newsletter above so you don’t miss anything.
DISCLAIMER: We are not registered investment advisers and the above analysis should be taken at face value only. We strongly advise against buying or selling CRISPR Therapeutics AG ($CRSP) based solely on our analysis above, and are not responsible for any losses that you may incur if you choose make any investment decisions based on the above.